Antipsychotic Drugs and Their Adverse Reactions - JA0008057-0000-19-152-H01-P

Antipsychotic Drugs and Their Adverse Reactions

by Brittani Zurek, PharmD
JA0008057-0000-19-152-H01-P
(4.6 / 58 ratings )

This course is credentialed for:
Pharmacy (2.00 Contact Hr)

Summary:

Schizophrenia is the most common psychotic illness in the U.S., affecting 1% of the population. Not only do these patients have a life expectancy that is 20-30 years shorter than the general population, but they also suffer from a drastically reduced quality of life. The management of schizophrenia is a large economic burden on the U.S. healthcare system. Studies have demonstrated that relapsed patients have healthcare costs that are three times higher than those of patients whose disease is stable. Schizophrenia is treated with antipsychotic medications, but noncompliance can result in ineffective therapy. Many schizophrenic patients have difficulty remembering to take their medications or have negative connotations associated with them. Additionally, antipsychotic medications are frequently discontinued due to adverse events. Without proper treatment, many of these patients relapse and require frequent hospitalizations.

Objectives:

The goal of this continuing education module is to provide a comprehensive review of antipsychotic medications and their safety profiles. After studying the information presented here, you will be able to:
  • Discuss the diagnostic symptoms of psychosis, schizophrenia, and bipolar disorders
  • Identify differences between first- and second-generation antipsychotics
  • List FDA-approved antipsychotics and their indications
  • Define the mechanisms behind antipsychotic efficacy and adverse events
  • Identify potential adverse reactions associated with antipsychotics
  • Assess incidence of adverse events associated with particular antipsychotic medications
 

 
Accreditation Information
 
The course is intended for pharmacists
 
Jointly Accredited Provider logoIn support of improving patient care, OnCourse Learning (a Relias LLC company) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
OnCourse Learning is also approved by the Florida Board of Pharmacy (provider # 50-1489).
 
Type of Activity: Knowledge
 
Initial Release Date: 05/10/2019; Planned Expiration Date: 12/31/2019